ArticleBiochemistry and biophysics reports2026
Optimization of PEI-mediated transient transfection for antibody production in Expi293F cells by iron ion supplementation.
Article in Biochemistry and biophysics reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polyethylenimine (PEI)-mediated transient transfection represents a pivotal methodology for recombinant protein production in HEK293 and derived cell lines. Despite extensive application, substantial potential for enhancement in transfection efficiency and exogenous protein expression persists, with the role of metal ions remaining inadequately characterized. We hypothesized that iron ions exert a concentration-dependent, biphasic regulation on PEI-mediated transfection, affecting both extracellular complex formation and intracellular gene expression. To test this hypothesis, we systematically investigated the impact of ferric ammonium citrate (FAC) on transient transfection efficiency and anti-PD-1 antibody production in Expi293F cells. Supplementation of iron-depleted basal medium with 10 μM FAC was identified as optimal, achieving 63.7% transfection efficiency for enhanced green fluorescent protein (eGFP) and an anti-PD-1 antibody yield of 55.0 mg/L. Transmission electron microscopy analysis revealed that FAC modulates transfection efficiency by altering PEI/DNA complex morphology. Quantitative real-time PCR demonstrated significant enhancement of intracellular DNA transcription by both FAC and calcium ions. The histone deacetylase inhibitor valproic acid further augmented transcription efficiency by 2.8-fold. Ultimately, anti-PD-1 monoclonal antibody production reached 171.0 mg/L in a 3-L bioreactor, representing a 10.6-fold improvement over initial conditions. This study provides preliminary evidence for establishing an efficient transient expression platform while offering initial mechanistic insights into how iron ions influence PEI-mediated transfection via complex morphology and transcriptional regulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.